As of Q4'25, ETN reported R&D Expenses of USD 203M and SG&A Expenses of USD 1.01B, marking slight increases from the previous quarter. This latest data point highlights that SG&A remains the dominant component of operating expenses. From Q1'23 to Q4'25, both R&D and SG&A Expenses have shown moderate growth with some quarter-to-quarter fluctuations. R&D Expenses rose from USD 179M in Q1'23 to USD 203M in Q4'25, while SG&A Expenses increased from USD 904M to USD 1.01B over the same period. Notably, SG&A Expenses peaked at USD 1.15B in Q2'25 before declining, indicating some volatility, whereas R&D spending has remained relatively stable with a gradual upward trend.